A drug–drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers

PURPOSE: Peficitinib is an oral pan-Janus kinase inhibitor for the treatment of rheumatoid arthritis. Co-administration of peficitinib with metformin, a type 2 diabetes therapy, can occur in clinical practice. Hepatic and renal uptake of metformin is mediated by organic cation transporter 1 (OCT1) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Mai, Toyoshima, Junko, Kaneko, Yuichiro, Oda, Kazuo, Nishimura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351850/
https://www.ncbi.nlm.nih.gov/pubmed/32472157
http://dx.doi.org/10.1007/s00228-020-02876-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351850/
https://www.ncbi.nlm.nih.gov/pubmed/32472157
http://dx.doi.org/10.1007/s00228-020-02876-2

Ejemplares similares